Department of Neurology

The Department of Neurology at the Saitama Medical University Medical Center was established in 2004 and has young and lively classrooms that are advancing every day. The Department of Neurology treats and conducts research on various neurological disorders, including immunologic neurological diseases, peripheral neurological disorders, cerebrovascular disorders, and neuro-denegenerdive.

Our department accepts more than 250 cerebrovascular disease patients throughout the year, and performs tPA treatment, which is the latest ultra-acute treatment, and neuro-endovascular catheter treatment, treatment from the acute phase to convalescence, and is also actively engaged in rehabilitation treatment from the acute stage.

On the research side, we not only provide medical treatment for intractable neurological diseases, but also conduct research on diseases such as intractable neurological diseases, and are a member of the Ministry of Health, Labor and Welfare research group for overcoming intractable diseases and immune neurological disorders. The latest treatments using immunotherapy (steroid therapy, immunoglobulin therapy, plasmapheresis, immunosuppression therapy, etc.) are performed as treatments for immunologic neurological diseases such as multiple sclerosis, encephalitis, myelitis, Guillain-Barre syndrome, and myasthenia gravis, and in recent years, the research and development of the pioneering treatment of plasmapheresis has been getting good results and is internationally acclaimed. In addition, the main focus is on the pathology of the disease and its new treatment with measures such as peripheral blood T/B cell subset, serum cytokines, oxidative stress, antioxidant power, and various autoantibodies. We have realized actual clinical feedback based on the latest knowledge. In addition, we are also actively introducing the latest treatments from clinical trials for neurological intractable diseases.

Our department performs medical treatments for a variety of neurological disorders, including cerebrovascular disorders, immunological neurological diseases, peripheral neurological disorders, neuro-degenerative diseases, headaches, dementia, and epilepsy.
In particular, the latest treatments using immunotherapy (steroid therapy, immunoglobulin therapy, plasmapheresis, immunosuppression therapy, and so on) are performed as treatments for immunologic neurological diseases such as multiple sclerosis, encephalitis, myelitis, Guillain-Barre syndrome, and myasthenia gravis, and in recent years, the research and development of the pioneering treatment of plasmapheresis has been getting good results and is internationally acclaimed.
We have established a specialty outpatient clinic for each disease, and we provide advanced treatment for patients.

The diseases that are the target of the Department of Neurology develop from the brain to the spinal cord, the nerves of the limbs and the muscular areas and are quite varied.
Specific examples are a stroke as brain disease (cerebral infarction, cerebral hemorrhage), Parkinson's disease, encephalitis, and meningitis. peripheral nerve include Guillain-Barre syndrome (GBS), diabetic peripheral neuropathy, and various neuralgia. Muscle diseases include dystrophia myotonica.

Neurological intractable diseases include immunological neurological disorders (multiple sclerosis (MS), myasthenia gravis (MG), Guillain-Barre syndrome, chronic inflammatory demyelinating polyneuropathy (CIDP), amyotrophic lateral sclerosis (ALS), and spinocerebellar degeneration.
Others include headaches, epilepsy, dementia, cervical and lumbar disease.

Because the "target diseases of the Department of Neurology" cover a wide range, we are actually examining various cases. The main symptoms that patients complain of include a wide variety, such as "headaches, numbness of their limbs, dizziness, forgetfulness, trembling of their limbs, weakness of their limbs, cramps, limbs that move without intention, trouble swallowing, inarticulate speaking, double vision, grow tired easily, droopy eyelids, unsteadiness."

We know that it is difficult for patients to determine whether they should visit the Department of Neurology. In such a case, one of the means is to consult your neighborhood doctor about your symptoms, and they can recommend a visit to the Department of Neurology clinic. In that case, the treatment in our department will proceed more smoothly if you can bring a letter of referral. Thank you.

The Department of Neurology was established in 2004 and has young and lively classrooms that are advancing every day. Our department is engaged in the treatment and research of various neurological diseases, including immune neurological diseases, peripheral neurological diseases, cerebrovascular disorders, and neurodegenerative diseases, etc.

We have received more than 250 cerebrovascular disease patients throughout the year and are in charge of treatment from acute to convalescence with the treatment of TPA therapy which is the ultra-acute phase treatment, and endovascular catheter treatment, and have been actively implementing rehabilitation treatment from acute stage.

On the research side, we conduct the latest research centering on neurological intractable diseases, and immunotherapy (steroid therapy, immunoglobulin therapy, plasmapheresis, immunosuppression therapy, etc.) for neuroimmunity diseases such as multiple sclerosis, encephalitis, myelitis, Guillain-Barre syndrome, myasthenia gravis. We are taking advantage of the latest treatments. In addition, we perform measurements of peripheral blood T and B cell subsets, various serum cytokines, various autoantibodies, and focus on the pathology of the disease and its new treatment. In addition, we are actively engaged in the presentation of academic papers and publications, and we have realized actual clinical feedback based on the latest knowledge.

The Department of Neurology handles a wide range of subject diseases which are often associated with other diseases and require a holistic response. As management including wide range of treatments is necessary, it is possible for students to acquire them evenly. We believe that it is the selling point of our department. By listening to the voices of all patients during the training period, and giving the medical treatments without being bound by neurological diseases, students will gain variable experiences in their internship. For the classification of inpatients, please refer to the results by medical treatment.